The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis
The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis
复制标题
DOI:
10.1128/mcb.00163-21
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Xiao-ai Lv
中科院分区:
文献类型:
--
作者:
Yin Duan;Hui-ling Chen;Min Ling;Shuo Zhang;Fei-xia Ma;Hong-chen Zhang;Xiao-ai Lv
EF24, a curcumin analog, exerts a potent antitumor effect on various cancers. However, whether EF24 retards the progression of triple-negative breast cancer.(TNBC) remains unclear. In this study, we explored the role of EF24 in TNBC and clarified.the underlying mechanism. In a mouse model of TNBC xenograft, EF24 administration.reduced the tumor volume, suppressed cell proliferation, promoted cell apoptosis, and.downregulated long noncoding RNA human leukocyte antigen complex group 11.(HCG11) expression. In TNBC cell lines, EF24 administration reduced cell viability,.suppressed cell invasion, and downregulated HCG11 expression. HCG11 overexpression reenhanced the proliferation and invasion of TNBC cell lines suppressed.by EF24. The following mechanism research revealed that HCG11 overexpression.elevated Sp1 transcription factor (Sp1) expression by reducing its ubiquitination,.thereby enhanced Sp1-mediated cell survival and invasion in the TNBC cell line..Finally, the in vivo study showed that HCG11-overexpressed TNBC xenografts exhibited.lower responsiveness in response to EF24 treatment. In conclusion, EF24 treatment.reduced HCG11 expression, resulting in the degradation of Sp1 expression, thereby inhibiting the proliferation and invasion of TNBC cells.